BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33403517)

  • 1. Examining the Factors Affecting PrEP Implementation Within Community-Based HIV Testing Sites in Florida: A Mixed Methods Study Applying the Consolidated Framework for Implementation Research.
    Turner D; Lockhart E; Wang W; Shore R; Daley E; Marhefka SL
    AIDS Behav; 2021 Jul; 25(7):2240-2251. PubMed ID: 33403517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PrEP Implementation Behaviors of Community-Based HIV Testing Staff: A Mixed-Methods Approach Using Latent Class Analysis.
    Turner D; Lockhart E; Wang W; Shore R; Daley EM; Marhefka SL
    J Acquir Immune Defic Syndr; 2020 Apr; 83(5):467-474. PubMed ID: 31939871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PrEP and Behavioral Health Treatment Referral Among HIV Test Counselors in Miami-Dade County: A Rapid Qualitative Study Using the Consolidated Framework for Implementation Research.
    Harkness A; Morales V; Atuluru P; Jaramillo J; Safren SA; Balise R; Turner D
    AIDS Behav; 2024 Mar; 28(3):820-836. PubMed ID: 37792227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of Implementation for HIV Pre-exposure Prophylaxis Based on an Updated Consolidated Framework for Implementation Research: A Systematic Review.
    Li DH; Benbow N; Keiser B; Mongrella M; Ortiz K; Villamar J; Gallo C; Deskins JS; Xavier Hall CD; Miller C; Mustanski B; Smith JD
    J Acquir Immune Defic Syndr; 2022 Jul; 90(S1):S235-S246. PubMed ID: 35703776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pragmatic approach to identifying implementation barriers and facilitators for a novel pre-exposure prophylaxis (PrEP) delivery model at public facilities in urban Uganda.
    Thomas D; Mujugira A; Ortblad K; Namanda S; Kibuuka J; Nakitende M; Nambi F; Nakabugo L; Scoville C; Muwonge T; Heffron R
    Implement Sci Commun; 2022 Jan; 3(1):7. PubMed ID: 35090560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing Disparities in Pre-Exposure Prophylaxis (PrEP) Access: Implementing a Community-Centered Mobile PrEP Program in South Florida.
    Butts S; Young B; Blackmon J; Doblecki-Lewis S
    Res Sq; 2023 Apr; ():. PubMed ID: 37162949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of community health worker intervention on PrEP knowledge and use in Rakai, Uganda: A mixed methods, implementation science evaluation.
    Edwards AJ; Pollard R; Kennedy CE; Mulamba J; Mbabali I; Anok A; Kong X; Nakyanjo N; Ddaaki W; Nishimura H; Wawer M; Amico KR; Hutton HE; Nakigozi G; Chang LW
    Int J STD AIDS; 2022 Oct; 33(11):995-1004. PubMed ID: 36006865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preexposure Prophylaxis Implementation in a Reproductive Health Setting: Perspectives From Planned Parenthood Providers and Leaders.
    Wilbourn B; Ogburn DF; Safon CB; Galvao RW; Kershaw TS; Willie TC; Taggart T; Caldwell A; Kaplan C; Phillips N; Calabrese SK
    Health Promot Pract; 2023 Jul; 24(4):764-775. PubMed ID: 35414273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Provider Perspectives on Factors Affecting the PrEP Care Continuum Among Black Cisgender Women in the Midwest United States: Applying the Consolidated Framework for Implementation Research.
    Johnson AK; Pyra M; Devlin S; Uvin AZ; Irby S; Blum C; Stewart E; Masinter L; Haider S; Hirschhorn LR; Ridgway JP
    J Acquir Immune Defic Syndr; 2022 Jul; 90(S1):S141-S148. PubMed ID: 35703766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the heterogeneity of factors that may influence implementation of PrEP in family planning clinics: a latent profile analysis.
    Piper KN; Haardörfer R; Escoffery C; Sheth AN; Sales J
    Implement Sci Commun; 2021 May; 2(1):48. PubMed ID: 33947472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peer ambassador stories: formative qualitative research to enhance the reach of PrEP, HIV testing, and behavioral health treatments to LMSM in South Florida.
    Jaramillo J; Reyes N; Atuluru P; Payen N; Taylor K; Safren SA; Saber R; Harkness A
    AIDS Care; 2024 Apr; 36(4):569-579. PubMed ID: 38157344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers to and strategies for early implementation of pharmacy-delivered HIV PrEP services in Kenya: An analysis of routine data.
    Nakambale HN; Roche SD; Mogere P; Omollo V; Kuo AP; Stergachis A; Baeten JM; Bukusi E; Ngure K; Mugambi ML; Ortblad KF
    Front Reprod Health; 2023; 5():1023568. PubMed ID: 36895656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementing PrEP Services in Diverse Health Care Settings.
    Faro EZ; Mantell JE; Gonzalez-Argoti T; Hoffman S; Edelstein Z; Tsoi B; Bauman LJ
    J Acquir Immune Defic Syndr; 2022 Jul; 90(S1):S114-S128. PubMed ID: 35703763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
    Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
    BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating PrEP delivery in public health family planning clinics: a protocol for a pragmatic stepped wedge cluster randomized trial in Kenya.
    Mugwanya KK; Matemo D; Scoville CW; Beima-Sofie KM; Meisner A; Onyango D; Mugambi M; Feutz E; Grabow C; Barnabas R; Weiner B; Baeten JM; Kinuthia J;
    Implement Sci Commun; 2021 Dec; 2(1):135. PubMed ID: 34895357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using qualitative comparative analysis to understand the conditions that produce successful PrEP implementation in family planning clinics.
    Piper KN; Anderson KM; Kokubun CW; Sheth AN; Sales J
    Implement Sci Commun; 2023 Jun; 4(1):64. PubMed ID: 37296455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial.
    Zablotska IB; Selvey C; Guy R; Price K; Holden J; Schmidt HM; McNulty A; Smith D; Jin F; Amin J; Cooper DA; Grulich AE;
    BMC Public Health; 2018 Feb; 18(1):210. PubMed ID: 29394918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scale up of PrEP integrated in public health HIV care clinics: a protocol for a stepped-wedge cluster-randomized rollout in Kenya.
    Mugwanya KK; Irungu E; Bukusi E; Mugo NR; Odoyo J; Wamoni E; Ngure K; Morton JF; Peebles K; Masyuko S; Barnabee G; Donnell D; Barnabas R; Haberer J; O'Malley G; Baeten JM;
    Implement Sci; 2018 Sep; 13(1):118. PubMed ID: 30180860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploratory survey of Florida pharmacists' experience, knowledge, and perception of HIV pre-exposure prophylaxis.
    Shaeer KM; Sherman EM; Shafiq S; Hardigan P
    J Am Pharm Assoc (2003); 2014; 54(6):610-7. PubMed ID: 25343624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of HIV pre-exposure prophylaxis for women of color: Perspectives from healthcare providers and staff from three clinical settings.
    Kimmel AL; Messersmith LJ; Bazzi AR; Sullivan MM; Boudreau J; Drainoni ML
    J HIV AIDS Soc Serv; 2021; 19(4):299-319. PubMed ID: 34456637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.